iOmx Therapeutics AG develops targeted immunotherapy treatments for cancer, utilizing innovative tumor immunology insights to create drug programs aimed at prevalent solid tumors. By focusing on unexplored immune evasion biology, iOmx distinguishes itself with a unique approach that includes biomarker-enabled treatments and first-in-class inhibitors.
No jobs found. Subscribe below to get notified when we find something for you.
Searching